OVRAL Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Ovral, and what generic alternatives are available?

Ovral is a drug marketed by Wyeth Pharms and is included in two NDAs.

The generic ingredient in OVRAL is ethinyl estradiol; norgestrel. There are twenty-six drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norgestrel profile page.

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for OVRAL?
What are the global sales for OVRAL?
What is Average Wholesale Price for OVRAL?

Summary for OVRAL

US Patents:	0
Applicants:	1
NDAs:	2
Raw Ingredient (Bulk) Api Vendors:	5
Patent Applications:	277
DailyMed Link:	OVRAL at DailyMed

Drug patent expirations by year for OVRAL

US Patents and Regulatory Information for OVRAL

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Wyeth Pharms	OVRAL	ethinyl estradiol; norgestrel	TABLET;ORAL-21	016672-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Wyeth Pharms	OVRAL-28	ethinyl estradiol; norgestrel	TABLET;ORAL-28	016806-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for OVRAL

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Wyeth Pharms	OVRAL	ethinyl estradiol; norgestrel	TABLET;ORAL-21	016672-001	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Wyeth Pharms	OVRAL	ethinyl estradiol; norgestrel	TABLET;ORAL-21	016672-001	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Wyeth Pharms	OVRAL	ethinyl estradiol; norgestrel	TABLET;ORAL-21	016672-001	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for OVRAL

See the table below for patents covering OVRAL around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
India	139097	PROCESS FOR PREPARING 13-ETHYLGON-4-ENES	⤷ Sign Up
Italy	1061784	PROCEDIMENTI PER LA PREPARAZIONE DI ESTERI DI STEROIDI	⤷ Sign Up
United Kingdom	1069846		⤷ Sign Up
Philippines	9894	13-ALKYL-GONA-1,3,5(10),9(11)-TETRAENES AND PROCESS OF THEIR MANUFACTURE	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

Supplementary Protection Certificates for OVRAL

Subscribe to access the full database, or Sign Up
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1453521	39/2015	Austria	⤷ Sign Up	PRODUCT NAME: ETHINYLESTRADIOL UND EINE KOMBINATION VON LEVONORGESTREL UND ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: 136021 20150224; FIRST REGISTRATION: SK 17/0017/15-S 20150211
1380301	CA 2009 00017	Denmark	⤷ Sign Up	PRODUCT NAME: ETHINYLESTRADIOL (SOM BETADEXCLATHRAT) OG DROSPIRENON; NAT. REG. NO/DATE: 42417 (DK) 20080619; FIRST REG. NO/DATE: NL 33842 20070629
1214076	49/2008	Austria	⤷ Sign Up	PRODUCT NAME: WIRKSTOFFKOMBINATION VON ETHINYLESTRADIOL UND DROSPIRENON; REGISTRATION NO/DATE: 1-27586 20080612
1453521	93156	Luxembourg	⤷ Sign Up	PRODUCT NAME: LEVONORGESTREL ET ETHINYLESTRADIOL; FIRST REGISTRATION DATE: 20150211
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

AI Research Assistant

Questions you can ask:

Summary for OVRAL

Make Better Decisions: Try a trial or see plans & pricing